OTLK logo

Outlook Therapeutics (OTLK) Debt To Equity Ratio

Annual Debt To Equity

-0.41
+2.05+83.33%

September 30, 2024


Summary


Performance

OTLK Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOTLKfinancial healthmetrics:

Quarterly Debt To Equity

-0.41
-0.02-5.13%

September 1, 2024


Summary


Performance

OTLK Quarterly Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOTLKfinancial healthmetrics:

Debt To Equity Formula

Debt To Equity =  
Total Debt
Shareholders Equity

OTLK Debt To Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+83.3%+72.7%
3 y3 years-115.9%-115.9%
5 y5 years+61.3%+54.4%

OTLK Debt To Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-115.9%+83.3%-113.5%+93.5%
5 y5-year-113.2%+83.3%-113.2%+93.5%
alltimeall time-113.2%+83.3%-108.3%+95.1%

Outlook Therapeutics Debt To Equity History

DateAnnualQuarterly
Sep 2024
-0.41(-83.3%)
-
Sep 2024
-
-0.41(+5.1%)
Jun 2024
-
-0.39(+18.2%)
Mar 2024
-
-0.33(-78.0%)
Dec 2023
-
-1.50(-39.0%)
Sep 2023
-2.46(-296.8%)
-2.46(-61.0%)
Jun 2023
-
-6.31(-307.6%)
Mar 2023
-
3.04(+50.5%)
Dec 2022
-
2.02(+61.6%)
Sep 2022
1.25(-51.6%)
1.25(+140.4%)
Jun 2022
-
0.52(-18.8%)
Mar 2022
-
0.64(+39.1%)
Dec 2021
-
0.46(-82.2%)
Sep 2021
2.58(-17.0%)
2.58(+180.4%)
Jun 2021
-
0.92(+67.3%)
Mar 2021
-
0.55(-150.9%)
Dec 2020
-
-1.08(-134.7%)
Sep 2020
3.11
3.11(+284.0%)
Jun 2020
-
0.81(-190.0%)
DateAnnualQuarterly
Mar 2020
-
-0.90(+57.9%)
Dec 2019
-
-0.57(-46.2%)
Sep 2019
-1.06(+23.3%)
-1.06(-87.4%)
Jun 2019
-
-8.41(+1457.4%)
Mar 2019
-
-0.54(-15.6%)
Dec 2018
-
-0.64(-25.6%)
Sep 2018
-0.86(+45.8%)
-0.86(-55.0%)
Jun 2018
-
-1.91(+67.5%)
Mar 2018
-
-1.14(-47.2%)
Dec 2017
-
-2.16(+266.1%)
Sep 2017
-0.59(-59.0%)
-0.59(+3.5%)
Jun 2017
-
-0.57(+32.6%)
Mar 2017
-
-0.43(-4.4%)
Dec 2016
-
-0.45(-68.8%)
Sep 2016
-1.44(+105.7%)
-1.44(-129.1%)
Jun 2016
-
4.95(-885.7%)
Mar 2016
-
-0.63(-44.2%)
Dec 2015
-
-1.13(+61.4%)
Sep 2015
-0.70(0.0%)
-0.70
Sep 2014
-0.70
-

FAQ

  • What is Outlook Therapeutics annual debt to equity ratio?
  • What is the all time high annual debt to equity for Outlook Therapeutics?
  • What is Outlook Therapeutics annual debt to equity year-on-year change?
  • What is Outlook Therapeutics quarterly debt to equity ratio?
  • What is the all time high quarterly debt to equity for Outlook Therapeutics?
  • What is Outlook Therapeutics quarterly debt to equity year-on-year change?

What is Outlook Therapeutics annual debt to equity ratio?

The current annual debt to equity of OTLK is -0.41

What is the all time high annual debt to equity for Outlook Therapeutics?

Outlook Therapeutics all-time high annual debt to equity ratio is 3.11

What is Outlook Therapeutics annual debt to equity year-on-year change?

Over the past year, OTLK annual debt to equity ratio has changed by +2.05 (+83.33%)

What is Outlook Therapeutics quarterly debt to equity ratio?

The current quarterly debt to equity of OTLK is -0.41

What is the all time high quarterly debt to equity for Outlook Therapeutics?

Outlook Therapeutics all-time high quarterly debt to equity ratio is 4.95

What is Outlook Therapeutics quarterly debt to equity year-on-year change?

Over the past year, OTLK quarterly debt to equity ratio has changed by +1.09 (+72.67%)